Molecular Mechanism of Ganglion Cell Death in Glaucoma
About the Research Project
Program
Award Type
Standard
Award Amount
$49,408
Active Dates
April 01, 1999 - March 31, 2001
Grant ID
G1999007
Summary
Susceptibility to glaucoma may be governed by multiple genes affecting different parts of the eye, for example, genes affecting intraocular pressure in the anterior part of the eye. However, damage to the eye in the form of neuronal cell death is the critical event leading to blindness, and Dr. Nickells’ long-range goal is to identify genes that contribute to the survival of ganglion cells under various conditions, including conditions that may mimic human glaucoma. To simplify the search for these genes, he proposes that strains of mice need to be developed that can be easily measured for changes in ganglion cell number. He is working to develop mice that express a marker gene that can be used to rapidly screen for the phenotype of ganglion cell variation. These mice can then be used for identifying the genes affecting ganglion cell survival.
Related Grants
National Glaucoma Research
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
National Glaucoma Research
Assessment of Vascular Resistance in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Brad Fortune, OD, PhD
Current Organization
Legacy Devers Eye Institute
Assessment of Vascular Resistance in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Brad Fortune, OD, PhD
Current Organization
Legacy Devers Eye Institute
National Glaucoma Research
Interleukin-10 As a Neuroprotective Factor in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Tatjana Jakobs, MD
Current Organization
The Schepens Eye Research Institute, Mass. Eye and Ear
Interleukin-10 As a Neuroprotective Factor in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Tatjana Jakobs, MD
Current Organization
The Schepens Eye Research Institute, Mass. Eye and Ear